Systemic lupus erythematosus in Zimbabwe.

Por Taylor, H G, Stein, C M
Publicado em 1986

Acute tropical polyarthritis in Zimbabwe: a prospective search for a gonococcal aetiology.

Por Stein, C M, Hanly, M G
Publicado em 1987

Novel polymorphisms in TICAM2 and NOD1 associated with tuberculosis progression phenotypes in Ethiopian populations

Por Mekonnen, E., Bekele, E., Stein, C. M.
Publicado no Glob Health Epidemiol Genom (2018)

Self-medication in urban and rural Zimbabwean communities.

Por Stein, C M, Gora, N P, Macheka, B M
Publicado em 1989

Lack of effect of paracetamol on the pharmacokinetics of chloramphenicol.

Por Stein, C M, Thornhill, D P, Neill, P, Nyazema, N Z
Publicado em 1989

Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension.

Por Stein, C M, Nelson, R, Deegan, R, He, H, Wood, M, Wood, A J
Publicado em 1995

Genetic polymorphism of (S)-mephenytoin 4′-hydroxylation in populations of African descent

Por Xie, H G, Kim, R B, Stein, C M, Wilkinson, G R, Wood, A J J
Publicado em 1999

Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction

Por Kurnik, D., Qasim, H., Sominsky, S., Lubetsky, A., Markovits, N., Li, C., Stein, C. M., Halkin, H., Gak, E., Loebstein, R.
Publicado em 2012

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

Por Scott, S A, Sangkuhl, K, Stein, C M, Hulot, J-S, Mega, J L, Roden, D M, Klein, T E, Sabatine, M S, Johnson, J A, Shuldiner, A R
Publicado em 2013

The DYX2 locus and neurochemical signaling genes contribute to speech sound disorder and related neurocognitive domains

Por Eicher, J. D., Stein, C. M., Deng, F., Ciesla, A. A., Powers, N. R., Boada, R., Smith, S. D., Pennington, B. F., Iyengar, S. K., Lewis, B. A., Gruen, J. R.
Publicado no Genes Brain Behav (2015)

Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update

Por Relling, M V, Gardner, E E, Sandborn, W J, Schmiegelow, K, Pui, C-H, Yee, S W, Stein, C M, Carrillo, M, Evans, W E, Hicks, J K, Schwab, M, Klein, T E
Publicado em 2013

Integration of genetic, clinical, and INR data to refine warfarin dosing

Por Lenzini, P., Wadelius, M., Kimmel, S., Anderson, J.L., Jorgensen, A.L, Pirmohamed, M., Caldwell, M.D., Limdi, N., Burmester, J.K., Dowd, M.B., Angchaisuksiri, P., Bass, A.R., Chen, J., Eriksson, N., Rane, A., Lindh, J.D., Carlquist, J.F., Horne, B.D., Grice, G., Milligan, P.E., Eby, C., Shin, J., Kim, H., Kurnik, D., Stein, C.M., McMillin, G., Pendleton, R.C., Berg, R.L., Deloukas, P., Gage, B.F.
Publicado em 2010